Literature DB >> 8254034

Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen.

B S Coller1, J L Kutok, L E Scudder, D K Galanakis, S M West, G S Rudomen, K T Springer.   

Abstract

The accessibility of activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to damaged blood vessels or atherosclerotic plaques is likely to play a crucial role in subsequent platelet recruitment. To define better the factors involved in this process, we developed a functional assay to assess the presence of activated, luminal GPIIb/IIIa receptors, based on their ability to bind erythrocytes containing a high density of covalently coupled RGD-containing peptides (thromboerythrocytes). Platelets readily adhered to wells coated with purified type I rat skin collagen and the adherent platelets bound a dense lawn of thromboerythrocytes. With fibrinogen-coated wells, platelet adhesion increased as the fibrinogen-coating concentration increased, reaching a plateau at about 11 micrograms/ml. Thromboerythrocyte binding to the platelets adherent to fibrinogen showed a paradoxical response, increasing at fibrinogen coating concentrations up to approximately 4-6 micrograms/ml and then dramatically decreasing at higher fibrinogen-coating concentrations. Scanning electron microscopy demonstrated that the morphology of platelets adherent to collagen was similar to that of platelets adherent to low density fibrinogen, with extensive filopodia formation and ruffling. In contrast, platelets adherent to high density fibrinogen showed a bland, flattened appearance. Immunogold staining of GPIIb/IIIa receptors demonstrated concentration of the receptors on the filopodia, and depletion of receptors on the flattened portion of the platelets. Thus, there is a paradoxical loss of accessible, activated GPIIb/IIIa receptors on the luminal surface of platelets adherent to high density fibrinogen. Two factors may contribute to this result: engagement of GPIIb/IIIa receptors with fibrinogen on the abluminal surface leading to the loss of luminal receptors, and loss of luminal filopodia that interact with thromboerythrocytes. These data provide insight into the differences in thrombogenicity between surfaces, and may provide a mechanism for purposefully passivating platelet-reactive artificial surfaces.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254034      PMCID: PMC288480          DOI: 10.1172/JCI116899

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets.

Authors:  B Savage; Z M Ruggeri
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

Review 2.  Regulatory functions of the vascular endothelium.

Authors:  J R Vane; E E Anggård; R M Botting
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

Review 3.  The platelet glycoprotein Ib-IX complex.

Authors:  Z M Ruggeri
Journal:  Prog Hemost Thromb       Date:  1991

4.  Thrombospondin-induced adhesion of human platelets.

Authors:  G P Tuszynski; M A Kowalska
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

5.  Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins.

Authors:  E Heilmann; P Hourdillé; A Pruvost; A Paponneau; A T Nurden
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

6.  Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel.

Authors:  B S Coller; D A Cheresh; E Asch; U Seligsohn
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

7.  Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets.

Authors:  N N Tandon; E A Holland; U Kralisz; H K Kleinman; F A Robey; G A Jamieson
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

8.  Laminin receptor on platelets is the integrin VLA-6.

Authors:  A Sonnenberg; P W Modderman; F Hogervorst
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

9.  Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment.

Authors:  M T Santos; J Valles; A J Marcus; L B Safier; M J Broekman; N Islam; H L Ullman; A M Eiroa; J Aznar
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin.

Authors:  I F Charo; L Nannizzi; J W Smith; D A Cheresh
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  7 in total

1.  Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells.

Authors:  Zachary Fulkerson; Tao Wu; Manjula Sunkara; Craig Vander Kooi; Andrew J Morris; Susan S Smyth
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

2.  Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading.

Authors:  Markéta Jirousková; Jyoti K Jaiswal; Barry S Coller
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

Review 3.  Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

Authors:  B S Coller
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

Review 4.  Synthetic Strategies for Engineering Intravenous Hemostats.

Authors:  Leslie W Chan; Nathan J White; Suzie H Pun
Journal:  Bioconjug Chem       Date:  2015-04-06       Impact factor: 4.774

Review 5.  Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen.

Authors:  Ashley C Brown; Erin Lavik; Sarah E Stabenfeldt
Journal:  Bioconjug Chem       Date:  2019-07-05       Impact factor: 4.774

6.  Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.

Authors:  Andrew J Shoffstall; Lydia M Everhart; Matthew E Varley; Eric S Soehnlen; Adam M Shick; Jeffrey S Ustin; Erin B Lavik
Journal:  Biomacromolecules       Date:  2013-07-24       Impact factor: 6.988

7.  Swing-out of the β3 hybrid domain is required for αIIbβ3 priming and normal cytoskeletal reorganization, but not adhesion to immobilized fibrinogen.

Authors:  Ming Cheng; Jihong Li; Ana Negri; Barry S Coller
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.